The Food and Drug Administration observed 213 examples of areas needing improvement during an eight-month inspection of blood services at the American Red Cross' national headquarters in Roslyn, Va., Red Cross officials said. The observations were in several categories, including donor management, hot line cases, information technology, internal audit management, inventory management, labeling processes and product manufacturing issues, the officials said. In an inspection completed in 2000, the FDA made 60 such observations. Red Cross officials said that the FDA agreed with them that the nation's blood supply is safer than ever; however, the officials also said they understand "more work needs to be done." At deadline, FDA officials were unavailable for comment. -- by Cinda Becker
FDA inspection finds flaws at Red Cross
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.